Search Results

MENLO PARK, Calif., April 17, 2013 - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.15 per share of common stock to be paid on June 28, 2013 to all common stockholders of record as of June 7, 2013.

Exponent anticipates paying quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors. 

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

MENLO PARK, Calif., April 17, 2013 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter ended March 29, 2013.

For the first quarter of 2013, revenues before reimbursements increased 4% to $68,992,000, as compared to $66,470,000 in the first quarter of 2012. Total revenues were $72,660,000, as compared to $71,925,000 in the same period one year ago.

Net income for the first quarter was $7,976,000, or $0.56 per diluted share, as compared to $8,201,000, or $0.57 per diluted share, reported in the same quarter one year ago. EBITDA¹ was $14,609,000, as compared to $14,800,000 in the first quarter last year.

During the first quarter, Exponent repurchased $11,700,000 of its common stock, and closed the quarter with $111,000,000 in cash, cash equivalents and short-term investments.

“The first quarter was better than we expected as we posted revenue growth and solid utilization,” commented Dr. Paul Johnston, President and CEO. “Following a slower January, we received some additional follow-on activities related to major assignments and continued to see a steady flow of new work. During the quarter we had notable performances in our electrical, thermal sciences, biomedical engineering, human factors, and engineering management and construction consulting practices.

“Looking forward we still expect 2013 revenues before reimbursements to be approximately flat with 2012. We are improving our 2013 outlook on EBITDA margin by 25 basis points to be down by 225 to 275 basis points as compared to the previous year. This guidance reflects the offsetting effects of reduced revenues from a few major assignments and defense work, with increased revenues from growth of the remaining business.

”We remain optimistic about our long-term ability to build upon our differentiated market position as a leading multi-disciplinary engineering and scientific consulting firm. We will continue to enhance shareholder value through stock repurchases and quarterly dividends,” concluded Dr. Johnston.

Financial Tables for Quarter Ending March 29, 2013

Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, April 17, 2013, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-2068 or 480-629-9712. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4613643#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, CA, April 10, 2013 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the first quarter ended March 29, 2013, immediately following the close of the market on Wednesday, April 17, 2013.  The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.  Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

 

A live webcast of this conference call will be available on the Investor Relations section of the Company’s website at www.exponent.com/investors.  It will also be available via replay beginning two hours after the completion of the call and through Thursday, April 25, 2013 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4613643#.

 

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. 

Exponent may be reached at (888) 656-EXPO, , or www.exponent.com.

MENLO PARK, Calif., February 19, 2013 - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared an initial quarterly cash dividend and authorized an additional stock repurchase plan.

The Company announced an initial quarterly cash dividend of $0.15 per share of common stock to be paid on March 29, 2013 to all stockholders of record as of March 8, 2013. Exponent expects to pay quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination by Exponent’s Board of Directors.

Exponent also announced that its Board of Directors has approved an additional $35 million dollars in share repurchases, adding to the Company’s existing $15.6 million available under the Company’s current authorization for repurchase. This plan authorizes Exponent to purchase its common stock in the open market or privately negotiated transactions in compliance with the Securities and Exchange Commission’s Rule 10b-18. In total, the Company now has $50.6 million of total authorization available to repurchase shares in open market transactions.

“During 2012, we generated more than $48 million in cash from operations and closed the year with $134 million in cash and short-term investments,” commented Dr. Paul Johnston, President and CEO. “Given our strong cash flow and balance sheet, we believe that a combination of stock repurchases and dividends will return value to shareholders. In summary, we believe these actions reflect our confidence in the strength and stability of our long-term financial position.”

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

MENLO PARK, Calif., January 30, 2013 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year ended December 28, 2012.

For the fourth quarter of 2012, revenues before reimbursements increased 7% to $65,049,000, as compared to $60,524,000 in the fourth quarter of 2011. Total revenues increased 7% to $72,946,000, as compared to $67,916,000 in the same period one year ago.

Net income for the fourth quarter increased 10% to $8,472,000, or $0.60 per diluted share, as compared to $7,731,000, or $0.54 per diluted share, reported in the same quarter one year ago. EBITDA1 improved 10% to $15,607,000, as compared to $14,139,000 in the fourth quarter last year.

For fiscal year 2012, revenues before reimbursements increased 8% to $266,562,000, as compared to $246,667,000, in 2011. Total revenues increased 7% to $292,653,000, as compared to $272,446,000 in the prior year.

Net income for fiscal year 2012 improved 14% to $37,225,000, or $2.60 per diluted share, as compared to $32,695,000, or $2.22 per diluted share, reported in the prior year. EBITDA1 improved 12% to $66,132,000, as compared to $58,994,000, in 2011.

During 2012, Exponent generated $48.5 million in cash flow from operations, repurchased $23.4 million of its common stock, and closed the year with $134.1 million in cash, cash equivalents and short-term investments.

“The fourth quarter concluded another good year of revenue growth and profitability for Exponent,” commented Dr. Paul Johnston, President and CEO. “During our fourth quarter, we experienced good demand for both proactive and reactive services and continued to benefit from activity related to a few major assignments – resulting in high utilization despite our seasonally slower quarter. Additionally, our defense technology development practice had strong surveillance system product sales.

“Throughout 2012, we assisted a wide range of clients in addressing significant technological, health and environmental matters by leveraging our breadth of disciplines and depth of engineering and scientific knowledge. We grew our consulting staff while achieving record utilization.

“For the year, we had notable contributions in our environmental and health segment from our environmental sciences, ecological sciences, and chemical regulation and food safety practices. In our engineering and other scientific segment we had notable performances from our mechanics and materials, electrical, thermal, and engineering management consulting practices.

“We previously communicated that over the last couple of years a few major assignments have accounted for a greater than usual percentage of revenues, and that there would be an impact on year-over-year revenue growth and profit margins when these assignments stepped down. As we enter 2013 we have experienced this anticipated step-down in these major assignments. Additionally, we are seeing the impact of constraints on defense spending and the reduction of forces in Afghanistan. As a result we expect 2013 revenues before reimbursements to be approximately flat with 2012 and EBITDA1 margin to be down 250 to 300 basis points.

“As we look forward we will continue to build upon our differentiated market position as a multidisciplinary engineering and scientific consulting firm with unparalleled technical expertise and experience. We remain optimistic about our market opportunities and look forward to translating these into long-term shareholder value,” concluded Dr. Johnston.

Financial Tables for Quarter Ending December 28, 2012

Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, January 30, 2013, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-2068 or 480-629-9712. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4588503#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

1 EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, CA, January 14, 2013 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the fourth quarter ended December 28, 2012, immediately following the close of the market on Wednesday, January 30, 2013.  The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.  Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s website at www.exponent.com/investors.  It will also be available via replay beginning two hours after the completion of the call and through Wednesday, February 6, 2013 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4588503#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. 

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., October 17, 2012 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter and nine months ended September 28, 2012.

For the third quarter of 2012, total revenues increased 11% to $73,298,000, as compared to $65,951,000 in the third quarter of 2011. Revenues before reimbursements increased 9% to $66,725,000, as compared to $61,387,000 in the same period one year ago.

Net income for the quarter increased 17% to $10,225,000, or $0.72 per diluted share, as compared to $8,744,000, or $0.60 per diluted share, reported in the same quarter a year ago. EBITDA¹ improved 13% to $17,383,000, as compared to $15,446,000 in the third quarter last year.

For the first nine months of 2012, total revenues increased 7% to $219,707,000, as compared to $204,530,000 in the same period of 2011. Revenues before reimbursements increased 8% to $201,513,000, as compared to $186,143,000, in the same period of last year.

Net income for the first nine months of 2012 increased 15% to $28,753,000, or $2.01 per diluted share, as compared to $24,964,000, or $1.67 per diluted share, reported in the prior year period. EBITDA1 in the first nine months of 2012 improved 13% to $50,525,000, as compared to $44,855,000, in the first nine months of 2011.

During the first nine months of 2012, Exponent repurchased $19.4 million of its common stock, and closed the period with $109.7 million in cash, cash equivalents and short-term investments.

“We again delivered strong revenue growth and profitability in the third quarter and are pleased with our performance,” commented Dr. Paul Johnston, President and CEO. “Demand in our proactive and reactive businesses was strong, and activity levels on a few major projects remained high. As a result, we had increased utilization.

“In our environmental and health segment we had notable contributions from our environmental sciences, ecological sciences, and chemical registration and food safety practices. In our engineering and other scientific segment we had notable performances from our mechanics and materials, electrical, thermal, human factors and engineering management consulting practices. Additionally, despite some expected surveillance system product sales pushing into the fourth quarter, defense technology development also made a meaningful contribution from several projects related to detection of improvised explosive devices.

“In summary, the third quarter performance positions Exponent for a strong 2012. As a result, we are again increasing our fiscal year 2012 outlook. We now expect growth in revenue before reimbursements to be in the high single digits and full year EBITDA1 margin to increase over the prior year. Our growth expectations are particularly significant given the strong 2011 comparable. We are optimistic about our long-term opportunities and remain focused on further translating our unique scientific and engineering capabilities into additional value,” concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, October 17, 2012, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-1427 or 480-629-9664. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4568755#.

Financial Tables for Quarter-Ending September 28, 2012

 

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, Calif., July 18, 2012 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter and six months ended June 29, 2012.

For the second quarter of 2012, total revenues increased 14% to $74,484,000, as compared to $65,106,000 in the same period one year ago. Revenues before reimbursements increased 13% to $68,318,000, as compared to $60,573,000 in the second quarter of 2011.

Net income for the quarter increased 26% to $10,327,000, or $0.72 per diluted share, as compared to $8,217,000, or $0.55 per diluted share, reported in the same quarter a year ago. EBITDA1 improved 22% to $18,342,000, as compared to $14,987,000 in the second quarter last year.

For the first half of 2012, total revenues increased 6% to $146,409,000, as compared to $138,579,000 in the same period of last year. Revenues before reimbursements increased 8% to $134,788,000, as compared to $124,756,000, in the same period of 2011.

Net income for the first half of 2012 increased 14% to $18,528,000, or $1.29 per diluted share, as compared to $16,220,000, or $1.08 per diluted share, reported in the prior year period. EBITDA¹ in the first half of 2012 improved 13% to $33,142,000, as compared to $29,409,000, in the first half of 2011.

During the second quarter of 2012, Exponent repurchased $14.4 million of its common stock, and closed the quarter with $109.0 million in cash, cash equivalents and short-term investments.

“We are pleased with our second quarter performance having produced double-digit revenue growth and increased profitability,” commented Dr. Paul Johnston, President and CEO. “We continued to benefit from strong demand across a broad range of our services, both proactive and reactive. We experienced high utilization as we continued to benefit from new work in key areas as well as a few major projects. In our environmental and health segment we had notable contributions from our environmental sciences, ecological sciences, chemical registration and food safety, and exposure assessment practices. In our engineering and other scientific segment we had notable performances from our mechanics and materials, electrical, biomedical, vehicle, and engineering management consulting practices. In addition, our defense technology development business saw an increase in activity supporting the U.S. Army’s Rapid Equipping Force which was offset by the winding down of our current U.S. ground penetrating radar development contract.

“For the full year 2012, we are increasing our outlook for growth in revenue before reimbursements to be in the mid-single digits and expect full year EBITDA¹ margin to be approximately flat over the prior year. This outlook reflects the strong utilization during the first half of the year, our expectation that a few major projects will step down in their level of activity in the next several quarters, and lower defense technology development product sales as compared to the prior year. We are pleased with our performance to date and are optimistic about our ability to weather a difficult economic environment as our project work, both in the U.S. and internationally, are in areas that we believe are less sensitive to the economic slowdown. We look forward to further translating our unique scientific and engineering capabilities into additional shareholder value over time,” concluded Dr. Johnston.

Financial Tables for Quarter-Ending June 29, 2012

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, July 18, 2012, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-2068 or 480-629-9712. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4551395#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, Calif., July 9, 2012 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will release financial results for the second quarter ended June 29, 2012, immediately following the close of the market on Wednesday, July 18, 2012. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, July 25, 2012 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4551395#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

CONTACT: Exponent, Inc.
(888) 656-EXPO
info@exponent.com
www.exponent.com

MENLO PARK, Calif., April 18, 2012 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter ended March 30, 2012.

For the first quarter of 2012, revenues before reimbursements increased 4% to $66,470,000 as compared to $64,183,000 in the first quarter of 2011. Total revenues were $71,925,000, as compared to $73,473,000 in the same period one year ago.

Net income for the first quarter increased to $8,201,000, or $0.57 per diluted share, as compared to $8,003,000, or $0.53 per diluted share, reported in the same quarter one year ago. EBITDA1 improved to $14,800,000, as compared to $14,422,000 in the first quarter last year.

During the first quarter, Exponent repurchased $4.0 million of its common stock, leaving $40.4 million available under its currently authorized repurchase program. The Company closed the quarter with $103.7 million in cash, cash equivalents and short-term investments.

“We are pleased with our performance in the first quarter, especially considering the difficult comparison to the same quarter last year when we had significant defense product sales,” commented Dr. Paul Johnston, President and CEO. “During the quarter, we experienced good demand for both reactive and proactive services. We achieved higher utilization while also adding to our consulting staff and carefully managing expenses. Notable performances in the quarter included our mechanics and materials, electrical and thermal sciences practices, as well as our health and environmental groups.

“The first quarter was a solid start to fiscal year 2012, for which we continue to expect growth in revenue before reimbursements to be in the low- to mid-single digits. This growth has been tempered by the fact that our largest projects in 2011 accounted for a greater percentage of our revenues than in a typical year. We expect these projects will be stepping down in their level of activity over the next several quarters. As a result we expect 2012 utilization to be lower by a percentage point or two as compared to last year, and the EBITDA1 margin will be down slightly. We remain optimistic about our ability to leverage our multidisciplinary approach and expertise to capitalize on new market opportunities as we expand our business,” concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, April 18, 2012, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-4774 or 480-629-9760. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4531659#.

Financial Tables for Quarter Ended March 30, 2012



About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, net interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, CA, April 10, 2012 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the first quarter ended March 30, 2012, immediately following the close of the market on Wednesday, April 18, 2012. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s website at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Thursday, April 26, 2012 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4531659#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, , or www.exponent.com.

MENLO PARK, Calif., February 13, 2012 - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has approved an additional $35 million for stock repurchase. In addition to the $9.4 million still available from a 2011 authorization the total now available for repurchase is $44.4 million. This authorizes Exponent to purchase its common stock in the open market or privately negotiated transactions in compliance with Securities and Exchange Commission’s Rule 10b-18.

During 2011, Exponent generated $46.6 million in cash flow from operations, repurchased one million shares of its common stock for $40.6 million, and closed the year with $109.7 million in cash, cash equivalents and short-term investments.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

MENLO PARK, Calif., November 30, 2011- Exponent, Inc. (Nasdaq: EXPO) today announced that Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the William Blair & Co. 2nd Annual Global Services Growth Stock Conference on December 6, 2011, at 3:40 p.m. Mountain Time (2:40 p.m. Pacific Time), at the Four Seasons Resort in Scottsdale, AZ.

The presentation will be audio webcast and can be accessed via the company’s website at /investors/.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, CA, October 5, 2011 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the third quarter ended September 30, 2011, immediately following the close of the market on Wednesday, October 19, 2011. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, October 26, 2011 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4478201#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., July 20, 2011 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter and six months ended July 1, 2011.

For the second quarter of 2011, total revenues increased 8% to $65,106,000, as compared to $60,439,000 in the same period one year ago. Revenues before reimbursements increased 10% to $60,573,000, as compared to $55,128,000 in the second quarter of 2010.

Net income for the quarter was up 13% to $8,217,000, or $0.55 per diluted share, as compared to $7,280,000, or $0.48 per diluted share, reported in the same quarter a year ago. EBITDA¹ improved 13% to $14,987,000, as compared to $13,293,000 in the second quarter last year.

During the second quarter of 2011, Exponent repurchased $16 million of its common stock, bringing the 2011 year-to-date repurchase total to $23 million. The Company closed the second quarter with $95 million in cash, cash equivalents and short-term investments.

For the first half of 2011, total revenues increased 16% to $138,579,000, as compared to $119,845,000 in the same period of last year. Revenues before reimbursements increased 13% to $124,756,000, as compared to $110,329,000, in the same period of 2010.

Net income for the first half of 2011 improved 20% to $16,220,000, or $1.08 per diluted share, as compared to $13,519,000, or $0.90 per diluted share, reported in the prior year period. EBITDA1 in the first half of 2011 improved 18% to $29,409,000, as compared to $24,833,000, in the first half of 2010.

“We are pleased with our performance in the quarter, showing continued revenue growth and profitability,” commented Dr. Paul Johnston, President and CEO. “Our utilization remained strong as we experienced sustained demand related to a few major assignments. We had notable contributions from our mechanics and materials, electrical, thermal sciences, and human factors practices.

“Looking forward, we are mindful of the comparison against an unusually strong second half of 2010, where utilization and product sales were significantly higher than historical levels. Nevertheless given our strong performance in the first half of 2011, we are now raising our full-year expectations for EBITDA1 margin to be only slightly down and for growth in revenue before reimbursements to be in the high single digits, as compared to 2010.

“We added key talent in the quarter, expanding our breadth of disciplines and depth of knowledge in engineering and science. Our professionals continue to demonstrate the appropriate expertise and experience to answer clients’ important technology, health, and environmental questions,” concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, July 20, 2011, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-2068 or 480-629-9712. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4456038#.

Financial Tables for the Quarter Ending July 1, 2011 and July 2, 2010 (PDF)

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, CA, July 11, 2011 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the second quarter ended July 1, 2011, immediately following the close of the market on Wednesday, July 20, 2011. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, July 27, 2011 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4456038#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., June 1, 2011 - Exponent, Inc. (Nasdaq: EXPO) announced today that its Board of Directors has authorized up to an additional $35 million for the repurchase of Exponent’s common stock in the open market or privately negotiated transactions in compliance with Securities and Exchange Commission’s Rule 10b-18.  

 “This action reflects our confidence in the future cash flow of the Company, as well as our ongoing commitment to build long-term shareholder value,” commented Paul Johnston, President and Chief Executive Officer.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

MENLO PARK, Calif., May 12, 2011 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the B. Riley & Co. 12th Annual Investor Conference on Tuesday, May 24, 2011 and at the William Blair & Co. 31st Annual Growth Conference on Tuesday, June 14, 2011.

B. Riley & Co. 12th Annual Investor Conference
Date: Tuesday, May 24, 2011
Presentation Time: 1:30 p.m. PT
Location: Loews Santa Monica Beach Hotel, Santa Monica, CA

William Blair & Co. 31st Annual Growth Stock Conference
Date: Tuesday, June 14, 2011
Presentation Time: 9:30 a.m. CT (7:30 a.m. PT)
Location: Four Seasons Hotel, Chicago, IL

These presentations will be webcast and can be accessed via the company's website.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., April 20, 2011 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter ended April 1, 2011.

For the first quarter of 2011, total revenues grew 24% to $73,473,000, as compared to $59,406,000 in the same period one year ago. Revenues before reimbursements increased 16% to $64,183,000, as compared to $55,201,000 in the first quarter of 2010. Net income for the quarter was up 28% to $8,003,000, or $0.53 per diluted share, as compared to $6,239,000, or $0.42 per diluted share, reported in the same quarter a year ago. EBITDA¹ improved 25% to $14,422,000, as compared to $11,540,000 in the first quarter last year.

During the first quarter of 2011, Exponent repurchased $7.1 million of its common stock, and closed the quarter with $92.3 million in cash, cash equivalents and short-term investments.

“We are pleased to have delivered strong first quarter results,” commented Dr. Paul Johnston, President and CEO. “During the quarter we continued to see elevated levels of activity on a number of major assignments which engaged consultants across many of our practices. As a result utilization was up as compared to the same period a year ago. We had notable contributions from our defense technology development, biomechanics, biomedical engineering, and thermal science practices, as well as our environmental and health groups. Additionally, we had significant year over year growth in product sales of the Rapidly Deployed Surveillance Systems."

“For the full year 2011 we expect growth in revenue before reimbursements to be in the mid-single digits. The second half of 2011 compares to an unusually strong 2010, in which we had utilization and product sales that were higher than historical levels. As some of our major assignments move beyond the initial intense investigatory phase, we anticipate activity levels to gradually step down, but most likely continue for several quarters or years. For 2011, we expect utilization to be in the high sixties and to experience a slight decrease in the EBITDA¹ margin when compared to the prior year. "

“We are pleased that the talent, which we have added and developed over the past several years, has the appropriate knowledge and experience to assist clients with the significant technology, health, and environmental challenges that they are facing today. We will continue our focus on adding the best engineers and scientists and developing the skills necessary to expand upon our unique market position,” concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, April 20, 2011, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-8418 or 480-629-9809. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4432942#.

Financial Tables for Quarter-Ended April 1, 2011 and April 2, 2010

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

MENLO PARK, CA, April 12, 2011 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the first quarter ended April 1, 2011, immediately following the close of the market on Wednesday, April 20, 2011. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, April 27, 2011 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4432942#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., March 7, 2011- Exponent, Inc. (Nasdaq: EXPO) today announced that Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the Credit Suisse 13th Annual Global Services Conference on Tuesday, March 15th, 2011 and at the Sidoti & Company 15th Annual Emerging Growth Institutional Investor Forum on Tuesday, March 22nd, 2011.

Credit Suisse 13th Annual Global Services Conference
Date: Tuesday, March 15th, 2011
Presentation Time: 10:30 a.m. MT (9:30 a.m. PT)
Location: The Phoenician Hotel, Scottsdale, AZ
*This presentation will be Webcast and can be accessed via the company’s website.

Sidoti & Company 15th Annual Emerging Growth Institutional Investor Forum
Date: Tuesday, March 22, 2011
Presentation Time: 8:00 a.m. ET (5:00 a.m. PT)
Location: Grand Hyatt Hotel, NYC, NY
*This presentation will not be Webcast.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, CA, January 18, 2011 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2010, immediately following the close of the market on Wednesday, February 2, 2011. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, February 9, 2011 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4401721#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or http://www.exponent.com.

MENLO PARK, Calif., Nov. 30, 2010 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the William Blair & Co. Global Services Growth Stock Conference on December 7, 2010, at 8:10 a.m. Mountain Time ( 7:10 a.m. Pacific Time), at the Four Seasons Resort in Scottsdale, AZ.

The presentation will be webcast and can be accessed via the company's website at /investors/.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

MENLO PARK, Calif., October 20, 2010 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter ended October 1, 2010.

For the third quarter of 2010, revenues before reimbursements increased 12% to $56,906,000, as compared to $50,666,000 in the third quarter of 2009. Total revenues increased 20% to $66,306,000, as compared to $55,245,000 in the same period one year ago.

Net income for the third quarter of 2010 increased 34% to $7,820,000, or $0.52 per diluted share, as compared to $5,833,000, or $0.39 per diluted share, reported in the third quarter of 2009. EBITDA1 in the third quarter of 2010 increased 33% to $14,251,000, as compared to $10,687,000 in the third quarter of 2009. As of the end of the quarter cash, cash equivalents and short-term investments were $92,071,000.

For the first nine months of 2010, revenues before reimbursements increased 6% to $167,235,000, as compared to $158,026,000, in the same period of 2009. Total revenues increased 6% to $186,151,000, as compared to $175,903,000 in the same period of last year.

Net income for the first nine months of 2010 improved 21% to $21,339,000, or $1.42 per diluted share, as compared to $17,616,000, or $1.17 per diluted share, reported in the prior year period. EBITDA1 in the first nine months of 2010 improved 22% to $39,084,000, as compared to $32,037,000, in the first nine months of 2009.

“We are very pleased with our third quarter financial results which benefited from particularly strong utilization and product sales,” commented Dr. Paul Johnston, President and CEO. “In the third quarter, we had strong performances in our defense technology development and mechanics and materials practices, as well as our environmental and health groups. We continued to leverage our unique engineering and scientific consulting expertise to address significant technical, health and environmental issues.

“For the full year 2010, we expect to increase revenue before reimbursements in the mid single digits and improve EBITDA¹ margin by approximately 250 basis points. We continue to believe that Exponent offers unparalleled technical expertise and we continue to translate these capabilities into long-term shareholder value,” concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, October 20, 2010, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-8601 or 480-629-9810. A live webcast of the call will be available on the Investor Relations section of the Company's web site at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4373839#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

Financial Tables for Quarters Ended October 1, 2010 and October 2, 2009 (PDF)

MENLO PARK, CA, October 11, 2010 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the third quarter ended October 1, 2010, immediately following the close of the market on Wednesday, October 20, 2010.  The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.  Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

 

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors.  It will also be available via replay beginning two hours after the completion of the call and through Wednesday, October 27, 2010 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4373839#.

 

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or http://www.exponent.com.

MENLO PARK, Calif., September 27, 2010- Exponent, Inc. (Nasdaq: EXPO) today announced that Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the William Blair & Co. Emerging Growth Stock Conference on October 5, 2010, at 3:30 p.m. Eastern Time, at the InterContinental Barclay Hotel in New York City, NY.

The presentation will be webcast and can be accessed via the company’s website.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

MENLO PARK, Calif., July 21, 2010 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter ended July 2, 2010.

For the second quarter of 2010, revenues before reimbursements increased 5% to $55,128,000, as compared to $52,429,000 in the second quarter of 2009. Total revenues were $60,439,000, as compared to $60,862,000 in the same period one year ago.

Net income for the second quarter of 2010 increased 21% to $7,280,000, or $0.48 per diluted share, as compared to $6,025,000, or $0.40 per diluted share, reported in the second quarter of 2009. EBITDA¹ in the second quarter of 2010 increased 22% to $13,293,000, as compared to $10,938,000 in the second quarter of 2009.

During the second quarter of 2010, Exponent repurchased $2.3 million of its common stock, and closed the quarter with $76.4 million in cash, cash equivalents and short-term investments.

For the first half of 2010, revenues before reimbursements increased 3% to $110,329,000, as compared to $107,360,000, in the same period of 2009. Total revenues were $119,845,000, as compared to $120,658,000 in the same period of last year.

Net income for the first half of 2010 improved 15% to $13,519,000, or $0.90 per diluted share, as compared to $11,783,000, or $0.79 per diluted share, reported in the prior year period. EBITDA¹ in the first half of 2010 improved 16% to $24,833,000, as compared to $21,350,000, in the first half of 2009.

“We are pleased to report strong financial results in the quarter as a result of improved utilization and careful management of expenses,” commented Dr. Paul Johnston, President and CEO. “During the quarter we continued to experience a steady flow of reactive projects related to litigation, insurance claims and product recalls for which we were able to perform in-depth scientific research and analysis to determine what happened. Additionally, we have continued to assist clients in complying with regulations pertaining to the registration of chemicals used throughout the world. As a result, we had strong performances in our human factors and mechanics and materials practices, as well as our environmental and health groups."

“Our performance in the first half of the year provides a foundation for us to grow revenue before reimbursements in the low to mid single digits for fiscal year 2010 and to improve EBITDA1 margins while selectively hiring and investing in our future. We believe that Exponent continues to differentiate itself as a multidisciplinary engineering and scientific consulting firm with unparalleled technical expertise and experience,” concluded Dr. Johnston.

Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, July 21, 2010, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 888-549-7704 or 480-629-9857. A live webcast of the call will be available on the Investor Relations section of the Company's web site at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030 and entering reservation 4328776#.

About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

¹ EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

Financial Tables for Quarters Ended July 2, 2010 and July 3, 2009 (PDF)

MENLO PARK, CA, July 14, 2010 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the second quarter ended July 2, 2010, immediately following the close of the market on Wednesday, July 21, 2010. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, July 28, 2010 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4328776#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or http://www.exponent.com.

MENLO PARK, Calif., October 17, 2007 - Exponent, Inc. (Nasdaq: EXPO) today reported that it had been awarded an indefinite-delivery-indefinite-quantity (IDIQ), contract by the RDECOM Acquisition Center to deliver Rapid Deployment Integrated Surveillance Systems (RDISS), to the U.S. Army's Rapid Equipping Force that minimizes soldiers’ exposure to threats by providing continuous surveillance throughout Iraq and Afghanistan.